Moolec Science SA MLEC

Competitive advantage analysis · healthcare

Corporate Default
Overall moat score
52/100
Moderate

About Moolec Science SA

Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally. It develops nutritional supplements, food ingredients, meat replacements, and by-products using safflowers, chickpeas, fungi, soybeans, and yeast, as well as lupin and peas. The company … Full MLEC analysis →

Competitive advantage assessment

Key strengths

  • Cost Leadership Position Operating margin at 80.9th percentile with strong OpEx control demonstrates cost leadership.
  • Cash Generation Consistent Cash generation is consistent (score 0.86), indicating reliable business model.

Key risks

  • Liquidity Concerns Liquidity is concerning (score 0.03), raising questions about short-term obligations.
  • Revenue Volatility Signals Weak Stickiness Revenue volatility is high (stability score 0.00), suggesting weak customer stickiness.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Moderate
53

Where MLEC ranks in Biotechnology

Moolec Science SA ranks #215 of 713 scored companies in Biotechnology by moat score — the top 30%. The widest moat in the group is Royalty Pharma plc (RPRX) at 85/100.

Moat scores for companies ranked near MLEC in Biotechnology
# Company Moat score Rating
211 Pulmatrix, Inc. PULM 52/100 Moderate
212 FibroGen, Inc FGEN 52/100 Moderate
213 Edesa Biotech, Inc. EDSA 52/100 Moderate
214 Surrozen, Inc. SRZN 52/100 Moderate
215 Moolec Science SA MLEC 52/100 Moderate
216 Moolec Science SA Warrant MLECW 52/100 Moderate
217 Surrozen, Inc. Warrant SRZNW 52/100 Moderate
218 Verrica Pharmaceuticals Inc. VRCA 52/100 Moderate
219 PMV Pharmaceuticals, Inc. PMVP 52/100 Moderate

See every Biotech / Pre-Revenue company ranked by moat score →

How MLEC scores on the Corporate Default defenses

Pricing Power

Score 53 · 20% of the moat score

Pricing power is the ability to raise prices without losing volume.

Cost Advantage

Score 86 · 15% of the moat score

A cost advantage means delivering the same product for structurally less — better purchasing, denser distribution, a more automated process.

Customer Stickiness

Score 86 · 15% of the moat score

Stickiness is what makes revenue repeat without being re-won every year.

Capital Efficiency

Score 22 · 18% of the moat score

Capital efficiency asks what the company earns on the money tied up in the business.

Resilience

Score 40 · 17% of the moat score

Resilience is the capacity to get through a bad year on its own terms — enough liquidity, enough interest cover, and enough cash generation to avoid a rescue financing or a forced sale.

Scale & Market Position

Score 48 · 15% of the moat score

Scale matters only when it converts into economics.

How each Corporate Default defense is measured, in full →

Understanding MLEC's moat

What is Moolec Science SA's moat score?

Moolec Science SA (MLEC) scores 52 out of 100 on the StatsAlpha Moat Map, which rates its competitive advantage as moderate. It ranks #215 of 713 scored companies in Biotechnology, the top 30%. The score is a weighted composite of 6 competitive defenses, each measured against industry peers of 712 companies in Biotechnology. Its strongest defense is Cost Advantage (86/100) and its weakest is Capital Efficiency (22/100).

How does Moolec Science SA compare with other Biotechnology companies?

Moolec Science SA ranks #215 of 713 scored companies in Biotechnology by moat score. The widest moat in Biotechnology is Royalty Pharma plc (RPRX) at 85/100. The companies ranked closest are Surrozen, Inc. (SRZN) at 52 just above it and Moolec Science SA Warrant (MLECW) at 52 just below it.

How is the moat score calculated?

Each company is scored with an industry-specific template — Corporate Default in this case, chosen because the defenses that matter to a bank are not the ones that matter to a software company. Every defense combines several financial signals, and each signal is measured as a percentile against a peer group of 712 companies in Biotechnology. The defenses are then weighted to produce the overall score out of 100.

Why is Moolec Science SA scored with the Corporate Default template?

Most public companies sell a product or a service at a margin, so the moat question is whether that margin survives contact with competitors. The Corporate template scores the six defenses that show up in a general operating company's financial signature: whether it can hold price, produce more cheaply than rivals, keep its customers, earn a return above its cost of capital, withstand a downturn, and turn size into economics.

Which competitive defenses are measured for Moolec Science SA?

The Corporate Default template measures 6 defenses, and MLEC scores: Pricing Power (53), Cost Advantage (86), Customer Stickiness (86), Capital Efficiency (22), Resilience (40), Scale & Market Position (48). Each is scored independently as a percentile against peers, so a company can be strong on one and weak on another — the overall score reflects how those defenses are weighted for this industry.

Send Feedback
Please select a category.
0/1000